The significant reductions in serum concentrations of PD-L1, IL-1ra, and CCL4 suggest potential benefits of the intervention for obesity, with implications in many diseases such as diabetes, cancer, and autoimmune conditions. The gene discussed is CCL4; the disease is obesity due to melanocortin 4 receptor deficiency.